BRIM Biotechnology, Inc. (TPE:6885)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
New Drug Translation and Development Services		90.00K	526.00K	360.00K	90.77M
New Drug Translation and Development Services Growth		-82.89%	46.11%	-99.60%	-
Total		90.00K	526.00K	360.00K	90.77M
Total Growth		-82.89%	46.11%	-99.60%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Taiwan		90.00K	526.00K	360.00K	90.77M
Taiwan Growth		-82.89%	46.11%	-99.60%	-
Total		90.00K	526.00K	360.00K	90.77M
Total Growth		-82.89%	46.11%	-99.60%	-

Source: S&P Global Market Intelligence.